Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Cladribine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14,695Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioNxt Files Fast-Track US Patent for Sublingual Cladribine in MS
    BioNxt Files Fast-Track US Patent for Sublingual Cladribine in MS

    09 Oct 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxt-completes-%22fast-track%22-us-track-one-patent-filing-for-sublingu-1084504

    ACCESSWIRE
    09 Oct 2025
    Share Share
    Apotex’s Generics Cladribine Receives Tentative Approval in US
    Apotex’s Generics Cladribine Receives Tentative Approval in US

    08 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218425

    FDA
    08 Oct 2025
    Share Share
    Bionxt Advances Sublingual Cladribine For Multiple Sclerosis
    Bionxt Advances Sublingual Cladribine For Multiple Sclerosis

    29 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-29/bionxt-reports-sublingual-cladribine-multiple-sclerosis-drug-milestones-including-large-animal-study

    PHARMAWEB
    29 Sep 2025
    Share Share
    EMD Serono Showcases Mavenclad Durable Effects on RMS at ECTRIMS
    EMD Serono Showcases Mavenclad Durable Effects on RMS at ECTRIMS

    17 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250917584069/en/EMD-Serono-to-Present-New-Data-Highlighting-Durable-Effects-of-MAVENCLAD-in-Relapsing-Multiple-Sclerosis-RMS-at-ECTRIMS-2025

    BUSINESSWIRE
    17 Sep 2025
    Share Share
    Merck to Showcase MAVENCLAD's Durable Effects on RMS at ECTRIMS
    Merck to Showcase MAVENCLAD's Durable Effects on RMS at ECTRIMS

    17 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250917717443/en/Merck-to-Present-New-Data-Highlighting-Durable-Effects-of-MAVENCLAD-in-Relapsing-Multiple-Sclerosis-RMS-at-ECTRIMS-2025

    BUSINESSWIRE
    17 Sep 2025
    Share Share
    BioNxt Solutions Strengthens IP Protection for Sublingual
    BioNxt Solutions Strengthens IP Protection for Sublingual

    05 Aug 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxt-solutions-reports-pending-patent-grants-in-europe-and-eurasia-1056552

    ACCESSWIRE
    05 Aug 2025
    Share Share